Monthly GLP-1 for Obesity Promising as More Manageable Alternative

(MedPage Today) -- NEW ORLEANS--Injections of an ultra-long-acting investigational GLP-1 agonist led to significant weight loss in people with overweight or obesity, with reductions continuing after a switch to once-monthly dosing, according...